Valuation: Terumo Corporation

Market Cap 3,294B 20.34B 17.77B 16.43B 15.18B 28.59B 1,954B 29.1B 196B 76.88B 957B 76.4B 74.71B P/E 2027 *
19.7x
P/E 2028 * 17.7x
Enterprise Value 3,370B 20.81B 18.18B 16.81B 15.53B 29.24B 1,998B 29.77B 200B 78.64B 979B 78.15B 76.42B EV / Sales 2027 *
2.73x
EV / Sales 2028 * 2.52x
Free-Float
97.07%
Yield 2027 *
1.6%
Yield 2028 * 1.78%
1 day+0.88%
1 week-2.64%
Current month-0.04%
1 month+1.52%
3 months+4.64%
6 months-1.63%
Current year-1.63%
1 week 2,184.5
Extreme 2184.5
2,350
1 month 2,146.5
Extreme 2146.5
2,364.5
Current year 1,900
Extreme 1900
2,463
1 year 1,900
Extreme 1900
2,818
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 75 25/06/2020
Director/Board Member 63 21/06/2019
Chairman 68 01/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%-2.64%-9.25%+2.01% 20.11B
-2.70%-6.35%-32.02%-16.84% 160B
-5.01%-5.28%-11.51%-9.41% 107B
-1.45%-0.87%+1.60%+57.68% 59.56B
+0.35%-0.02%+43.33%+56.20% 52.51B
-1.38%-2.92%-14.32%-41.51% 42.39B
-3.91%-9.00% - - 34.31B
-3.64%+0.25%-13.56%-46.29% 29.46B
-0.18%+1.00%+60.20%-6.62% 25.41B
-3.73%-2.95%-7.42%-8.75% 21.15B
Average -2.03%-0.66%+1.89%-1.50% 55.23B
Weighted average by Cap. -2.49%-1.03%-7.37%-1.46%

Financials

2027 *2028 *
Net sales 1,236B 7.63B 6.67B 6.17B 5.7B 10.73B 733B 10.93B 73.56B 28.86B 359B 28.68B 28.04B 1,315B 8.12B 7.1B 6.56B 6.06B 11.41B 780B 11.62B 78.23B 30.69B 382B 30.5B 29.83B
Net income 166B 1.02B 893M 826M 763M 1.44B 98.17B 1.46B 9.85B 3.86B 48.07B 3.84B 3.75B 185B 1.14B 999M 924M 854M 1.61B 110B 1.64B 11.02B 4.32B 53.79B 4.3B 4.2B
Net Debt 75.69B 467M 408M 378M 349M 657M 44.89B 669M 4.5B 1.77B 21.98B 1.76B 1.72B 14.29B 88.24M 77.11M 71.28M 65.86M 124M 8.48B 126M 850M 334M 4.15B 331M 324M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
14/07/26 ¥2,233.00 +0.88% 3,221,300
13/07/26 ¥2,213.50 +1.12% 3,004,900
10/07/26 ¥2,189.00 -1.73% 4,601,900
09/07/26 ¥2,227.50 -2.15% 3,400,200
08/07/26 ¥2,276.50 -2.04% 5,188,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,233.00JPY
Average target price
2,961.54JPY
Spread / Average Target
+32.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock